Ambalal Sarabhai Enterprises’ arm starts new oncology, synthetic API plant in Vadodara

09 Jun 2023 Evaluate

Ambalal Sarabhai Enterprises’ subsidiary -- Asence Pharma has commenced its new oncology and synthetic API plant at Ranoli, Vadodara. The new API plant is set up to meet all domestic and international regulatory standards and will manufacture niche molecules that have a global requirement. 

Asence Pharma specializes in the supply of quality pharmaceutical preparations (Bulk Drugs and Formulations) to domestic and international markets. Asence through its operations in India and USA, markets and distributes pharmaceutical preparations worldwide and has more than 100 registered products internationally with an impressive pipeline and capability for development of new medicines.  

Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials. 


Ambalal Sarabhai Ent Share Price

48.03 0.23 (0.48%)
01-Jul-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1517.90
Dr. Reddys Lab 6362.00
Cipla 1478.90
Zydus Lifesciences 1066.95
Lupin 1614.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.